Dr. Holtorf is the founder of the Health Outcomes Strategies GmbH consulting agency (www.health-os.com). Her areas of expertise are value of healthcare products and policy decisions on healthcare products for the in- and off-patent sector, reimbursement strategies, outcomes research and health economics, health technology assessment processes, payer interactions, product / device / service synergies. Specifically, she has recently contributed to the development and implementation of Multi Criteria Decision Analysis instruments for improved decision processes in emerging markets including Thailand, Kuwait, and China. In addition, she is currently acting as engaged in initiatives for patient involvement in pharmaceutical R&D and health technology assessment (as Project Coordinator).
As member of the Health Technology Assessment international Association (HTAi) and the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) she is engaged in the workgroups for Patient and Citizen Involvement in HTA, for Precision Medicines Methods and for Health Technology Assessment for pharmaceuticals, medical devices and diagnostics. Dr. Holtorf has also been appointed as evaluator at the EU commission on multiple occasions including SME funding programs and serves on the permanent accreditation boards for university programs in Germany.
More speakers Announced soon
Please check back later for updates.
We are proud to announce that EPF Congress 2019 is Patients Included™. This means that EPF is committed to incorporating the experience of patients as experts in living with their condition while ensuring they were neither excluded nor exploited.More information